A randomized study about TURP complications due to Asiprin consumption

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200122046220N1

Enrollment

132

Registered

2020-04-24

Start date

2018-01-30

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trasurethral resection of prostat.

Interventions

Intervention 1: Intervention group: 66 patients referred to Sina Hospital who were Candidates for prostate surgery (TURP) and took 80 mg of aspirin daily before surgery,underwent a randomized clinical

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Benign Prostatic Hyperplasia

Exclusion criteria

Exclusion criteria: End Stage Renal Disease (ESRD) Cirrhosis Received anticoagulant medications

Design outcomes

Primary

Measure	Time frame
Post TURP hematuria due to Asiprin consumption. Timepoint: First 28 Days after TURP. Method of measurement: Hemoglobin decline.	—

Secondary

Measure	Time frame
Cardiac complication after TURP. Timepoint: First 28 days after TURP. Method of measurement: Cardiac enzyme checks in suspected cases.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Karimi Baba Ahmadi

Tehran University of Medical Sciences

arashkarimi86@yahoo.com+98 21 6693 8257

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026